A multicenter phase II trial of pre-operative chemotherapy with Gemcitabine/ Cisplatin /S-1 for biliary tract cancers with lymph node metastasis diagnosed by FDG-PET
Phase 2
- Conditions
- biliary tract cancers
- Registration Number
- JPRN-UMIN000009831
- Lead Sponsor
- KHBO
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 25
Inclusion Criteria
Not provided
Exclusion Criteria
1. Massive abdominal effusion requiring treatment. 2. Active concomitant malignancy. 3. The case suspected of infection. 4. Patients with water solubility diarrhea. 5. Mental disease or psychotic manifestation. 6. Under continuous steroid therapy. 7. Patients with acute myocardial infaction. 8. Patients with severe complications. 9. Pregnancy or the desire to preserve fecundity. 10. Serious drug hypersensitivity or a history of drug allergy. 11. Any patients judged by the investigator to be unfit to participate in the study.
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method